Fetal and maternal considerations in the management of stage I-B cervical cancer during pregnancy☆
References (8)
Cervical carcinoma associated with pregnancy
Lancet
(1982)- et al.
Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps
J. Pediatr.
(1983) - et al.
Cancer complicating pregnancy, Cancer of the cervix: Diagnosis and treatment
- et al.
A simplified score for assessment of fetal maturation of newly born infants
J. Pediatr.
(1979)
Cited by (71)
Cancer in pregnancy
2023, DiSaia and Creasman Clinical Gynecologic OncologyCancer in pregnancy
2018, Clinical Gynecologic OncologyManagement and outcome of cervical cancer diagnosed in pregnancy
2017, American Journal of Obstetrics and GynecologyCitation Excerpt :While the pregnant patients had a significantly longer delay from diagnosis to treatment, this did not seem to impact the overall oncologic outcome. In this setting, it may be reasonable to consider delaying delivery until at least 37 weeks’ gestation, if not 39 weeks, due to increasing pediatric literature about the risks of late preterm and early term birth.21-24 Many current studies of cervical cancer management in the context of pregnancy describe iatrogenic preterm birth to expedite maternal oncologic treatment.10,21,25
Cancer in Pregnancy
2012, Clinical Gynecologic Oncology: Eighth EditionRecurrence during pregnancy of a conservatively treated early-stage cervical squamous cell carcinoma
2011, Fertility and SterilityCitation Excerpt :Adenocarcinoma was diagnosed at the beginning of pregnancy, and medical abortion was performed at 9 weeks. Although there are few available data on this subject in the literature, pregnancy does not appear to worsen the prognosis of cervical cancer in its early stages (13–17). Finally, it is important to note that recurrence is encountered even after nonconservative management of cervical tumors (5, 6).
Cervical neoplasia in pregnancy. Part 2: current treatment of invasive disease
2008, American Journal of Obstetrics and Gynecology
- ☆
Presented at the Annual Meeting of The Western Association of Gynecologic Oncologists, May 13–16, 1987.